Pathogenesis and Treatment of Amyotrophic Lateral Sclerosis (ALS)
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 12
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue provides a comprehensive platform for advancing the understanding of amyotrophic lateral sclerosis (ALS) pathogenesis and accelerating the development of effective treatments. As a multifactorial neurodegenerative disease, ALS involves complex interactions between genetic susceptibility, molecular pathways, and cellular processes. We welcome original contributions that explore multi-target therapeutic strategies, including novel drug development and rational combination therapies designed to address the disease's heterogeneity. Submissions utilizing cutting-edge methodologies—such as artificial intelligence-based prediction models, multi-omics data integration, and patient-derived iPSC platforms—for target discovery, drug repurposing use, and patient stratification are particularly encouraged. The issue also seeks innovative clinical trial designs incorporating adaptive protocols, novel endpoint selection, and biomarker-guided strategies to enhance trial efficiency and accuracy. We invite research on diverse intervention modalities ranging from pharmacological approaches (including small molecules, gene therapies, cell-based treatments, and traditional medicines) to non-pharmacological interventions such as neuromodulation and rehabilitation strategies. A key emphasis is placed on translational research that successfully bridges mechanistic insights from basic science with practical clinical applications, ultimately aiming to delay disease progression, extend survival, and improve patients' symptoms and quality of life. The Special Issue invites both original research articles and comprehensive review papers that address these critical areas in ALS research.
Prof. Dr. Dongsheng Fan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- amyotrophic lateral sclerosis (ALS)
- multi-target therapy
- drug repurposing
- translational research
- biomarkers
- induced pluripotent stem cells (iPSCs)
- clinical trial design
- AI-based prediction models
- precise treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
